Aminoglykosider bør fortsatt brukes i empirisk sepsisbehandling
Paul Christoffer Lindemann Artikkel Bokmål
*0011185133 *008130612s2013 xx# 000 0 nob *019 $bk *08230$a616.94 *100 $aLindemann, Paul Christoffer$4aut$_140068700 *245 $aAminoglykosider bør fortsatt brukes i empirisk sepsisbehandling *300 $aS. 1054-1055 : ill. *650 $aSepsis$2norart$_13320500 *650 $aaminoglykosider$9nor$2norart$_140068800 *700 $aHaldorsen, Bjørg C.;$4aut$_140068900 *700 $aMylvaganam, Haima$4aut$_140069000 *700 $aSjursen, Haakon;$4aut$_139971400 *700 $aSmith, Ingrid;$4aut$_140069100 *773 $tTidsskrift for Den norske legeforening$gÅrg. 133, nr. 10 (2013)$x0029-2001$w(NO-LaBS)552783(tnr) *8564 $uhttps://doi.org/10.4045/tidsskr.13.0213 *999 $z1300538425$anorart:1300538425 ^